resources

Thyrocare Technologies Ltd.

NSE: THYROCARE

BSE: 539871

Sector: Healthcare

Industry Group: Healthcare Services

Industry: Healthcare Service Provider

494.65-4.8 (-0.96%)

14 Oct, 12:00 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Thyrocare Technologies Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Annual Reports	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Quarterly Results	—	—	Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun
Conference Calls	—	—	—	—	—	20Feb	9May 5Aug 14Nov	6Feb 4Aug 3Nov	5Feb 17May 27Jul 28Oct	27Jan 29Apr 28Jul 17Oct	2Feb 14May 27Jul
Presentations	—	—	—	—	—	1Feb 10May 13Aug 15Nov	12Feb 30Apr 1Aug 11Nov	3Feb 23May 1Aug 31Oct	1Feb 14May 23Jul 23Oct	23Apr 23Jul 14Oct	28Jan 7May 23Jul

Corporate Announcements and Regulatory Filings

Thyrocare Technologies Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20186 Oct 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find attached herewith Certificate pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026
Newspaper Publication29 Sept 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find attached the Copies of Newspaper Publications for Notice of Postal Ballot
Postal Ballot28 Sept 2026
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Please find attached herewith Notice of Postal Ballot dated September 21, 2026
General24 Sept 2026
Grant Of Employee Stock Options Under Thyrocare Employee Stock Option Scheme.
Please find attached herewith Intimation relating Grant of Options under Thyrocare Employee Stock Option Scheme
Closure of Trading Window24 Sept 2026
Closure of Trading Window
Please find attached the Intimation for Closure of Trading Window
General21 Sept 2026
Sale Of The Entire Shareholding Held By The Company In Nueclear Healthcare Limited (A Material Wholly Owned Subsidiary), Subject To The Approval Of The Shareholders Of The Company
Please find attached Intimation Letter
Acquisition21 Sept 2026
Announcement under Regulation 30 (LODR)-Acquisition
Please find attached intimation regarding Acquisition of Compulsorily Convertible Preference Shares of Trovera Healthcare Private Limited as part-consideration for the sale of Nueclear ....
General21 Sept 2026
Outcome Of The Board Meeting Held On Monday, September 21, 2026
Outcome of the Board meeting held on Monday, September 21, 2026
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 20119 Sept 2026
Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 08, 2026 for Docon Technologies ....
Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 20114 Sept 2026
Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for API Holdings Ltd
Newspaper Publication4 Sept 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith copies of Newspaper Publications published on September 04, 2026 in Business Standard (English) and Lakshadeep (Marathi)
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 20114 Sept 2026
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for API Holdings Ltd
General1 Sept 2026
Communication Received From API Holdings Limited Regarding Approval Of Scheme Of Amalgamation Of Docon Technologies Private Limited With API Holdings Limited
Please find enclosed the Intimation regarding approval of Scheme of Amalgamation of Docon Technologies Private Limited with API Holdings Limited
19 Aug 2026
Disclosure under Regulation 30A of LODR
Please find enclosed the Intimation regarding complete discharge and release of Transaction Documents pursuant to full redemption and repayment of Non-Convertible Debentures by API Holdings Limited
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201119 Aug 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201118 Aug 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Docon Technologies Pvt Ltd & PACs
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201118 Aug 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Docon Technologies Pvt Ltd
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 201118 Aug 2026
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for HSBC Mutual Fund
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 201118 Aug 2026
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 13, 2026 for Docon Technologies Pvt Ltd
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201118 Aug 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Docon Technologies Pvt Ltd & PAC

Frequently Asked Questions

Where can I download the annual report of Thyrocare Technologies Ltd.?

Annual reports of Thyrocare Technologies Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Thyrocare Technologies Ltd.?

Quarterly earnings results and presentations of Thyrocare Technologies Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Thyrocare Technologies Ltd. publish earnings call transcripts?

Earnings call transcripts of Thyrocare Technologies Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Thyrocare Technologies Ltd.?

Investor presentations and annual day presentations of Thyrocare Technologies Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Thyrocare Technologies Ltd.?

Corporate announcements and regulatory filings of Thyrocare Technologies Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Thyrocare Technologies Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Thyrocare Technologies Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Thyrocare Technologies Ltd.?

The ISIN (International Securities Identification Number) of Thyrocare Technologies Ltd. is INE594H01019. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Thyrocare Technologies Ltd. listed?

Thyrocare Technologies Ltd. is listed on NSE and BSE. The NSE symbol is THYROCARE and the BSE code is -.

Where can I find the shareholding pattern of Thyrocare Technologies Ltd.?

The quarterly shareholding pattern of Thyrocare Technologies Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Thyrocare Technologies Ltd. on Sharpely?

Share price data for Thyrocare Technologies Ltd. is updated as of 14 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.